Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Healthcare AI today: Billions for AI-based biotech, fast ROI or else, AI for imprisoned patients, more
The Zuckerbergs have many billions to give away. They want to shower a lot of it on researchers using AI to cure diseases.
Large-scale policy changes fail to boost heart failure outcomes—what else is needed?
A system-wide initiative in Sweden helped hospitals reduce readmission rates and shorten lengths of stay. When it came to heart failure patients specifically, however, the changes barely made an impact.
To eat or not to eat: Is fasting still necessary before heart procedures?
As one may expect, patient satisfaction was considerably higher for individuals who did not have to fast for a minimum of six hours prior to treatment. There were no other significant differences.
Healthcare AI today: Docs and clerks, talk therapy renewed, Dr. AI vs. Dr. Google, more
Not long ago, physicians and grocery clerks had a key duty in common: ‘connective labor.’ Today barcode reading machines sweep you through the checkout. And AI can handle most of your health questions.
Healthcare AI today: Rusty clinical skills, AI growing up so fast, AI for the malnourished
Clinicians who come to rely on AI for decision support risk the dulling of their skills. The concern is not new. But now comes a pointed call to researchers: Inquire about the particulars of the peril.

deep-penetrating acoustic volumetric printing 3D printing

New 3D-printing technique shows early potential to help heart patients

“We can reach tissues, bones and organs with high spatial precision that haven’t been reachable with light-based printing methods," one researcher explained.

FDA announces recall of Cardiohelp ECMO emergency drives due to serious risks

If the emergency drive is needed during treatment, it could fail to work, putting patients at risk of ischemia, hypoxia, stroke or death.

Dapagliflozin improves symptoms in some, but not all, heart failure patients

The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent.

Credit forecast: Hospitals will recover only slowly from lingering ‘labor-demic’

In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

ethical healthcare artificial intelligence

Ethical healthcare AI in 8 mnemonic elements

Artificial intelligence researchers are making a “great plea” to guide the ethical development and use of generative AI in medicine.

SavvyWire OpSens TAVR guidewire owned by Haemonetics

New 3-in-1 TAVR guidewire capable of hemodynamic measurements, LV pacing impresses cardiologists

The company behind the new technology was recently acquired for approximately $253 million.

Cardiologists, other physicians say the shift from private practice to corporate ownership is bad for patients

How do changes in ownership impact patient care? That was one of the many topics explored in a new survey of U.S. physicians.

Care Delivery

Healthcare AI today: Billions for AI-based biotech, fast ROI or else, AI for imprisoned patients, more

Large-scale policy changes fail to boost heart failure outcomes—what else is needed?

To eat or not to eat: Is fasting still necessary before heart procedures?

Healthcare AI today: Docs and clerks, talk therapy renewed, Dr. AI vs. Dr. Google, more

Healthcare AI today: Rusty clinical skills, AI growing up so fast, AI for the malnourished